HAILYN LEAL: Open Payments
NPI 1699367771 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 8 payments from 5 companies in 2025. Trend: 2023 $668 · 2024 $284 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $263 |
| Amgen Inc. | 2 | $180 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| Novartis Pharmaceuticals Corporation | 1 | $73 |
Products named: JARDIANCE, KRYSTEXXA, AUSTEDO XR, REXULTI, Fabhalta.
Industry payments across CA — which companies pay providers there.
